Will magic mushrooms be the cure for the $300 billion...
GreenStar Biosciences (CSE: GSTR) director and Eleusian Biosciences founder Jonathan Gilbert joins Small Caps to discuss the market potential of psychedelic medicine, specifically psilocybin mushrooms.Niv Dagan, executive director of Peak Asset Management, also joins the discussion on how psychedelics could revolutionise the mental health market and offer real solutions to modern day problems so many are facing.Eleusian Biosciences Corp is a Toronto based company focused on development of
en-au